Epanova
A formulation of EPA + DHA free fatty acids (not ethyl esters), used in the Strength study. Designed for better absorption but potentially caused GI irritation, possibly contributing to the study's negative results.
Videos Mentioning Epanova
Dr. Bill Harris on the Omega-3 Index: Increasing Omega-3 to Promote Longevity & Transform Health
FoundMyFitness
A formulation of EPA + DHA free fatty acids (not ethyl esters), used in the Strength study. Designed for better absorption but potentially caused GI irritation, possibly contributing to the study's negative results.
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Peter Attia MD
A free omega-3 fatty acid product containing both EPA and DHA, acquired by AstraZeneca, which failed to show efficacy in a clinical trial and was subsequently stopped.
#83 – Bill Harris, Ph.D.: Omega-3 fatty acids
Peter Attia MD
A drug from AstraZeneca containing EPA plus DHA in free fatty acid form, currently being studied in the STRENGTH trial for cardiovascular outcomes.